Nuclear Medicine in Finland

por Kairemo, Kalevi
Publicado 2012

Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer

por Kairemo, Kalevi, Hodolic, Marina
Publicado 2023

Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT

por Kairemo, Kalevi, Joensuu, Timo
Publicado 2015

Imaging of Accidental Contamination by Fluorine-18 Solution: A Quick Troubleshooting Procedure

por Kairemo, Kalevi, Kangasmäki, Aki
Publicado 2016

Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer

por Kairemo, Kalevi, Kangasmäki, Aki, Bom, Hee-Seung
Publicado 2019

Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT Imaging in Prostate Cancer Patients

por Kairemo, Kalevi, Rasulova, Nigora, Partanen, Kaarina, Joensuu, Timo
Publicado 2014

Radionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report

por Kairemo, Kalevi, Rasulova, Nigora, Suslaviciute, Justina, Alanko, Tuomo
Publicado 2014

Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives

por Subbiah, Vivek, Chuang, Hubert H., Gambhire, Dhiraj, Kairemo, Kalevi
Publicado 2017

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using...

por Kairemo, Kalevi, Kappadath, S. Cheenu, Joensuu, Timo, Macapinlac, Homer A.
Publicado 2020

Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics

por Kairemo, Kalevi, Joensuu, Timo, Rasulova, Nigora, Kiljunen, Timo, Kangasmäki, Aki
Publicado 2015

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Pros...

por Kairemo, Kalevi, Ravizzini, Gregory C., Macapinlac, Homer A., Subbiah, Vivek
Publicado 2017

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer

por Kairemo, Kalevi, Santos, Elmer B., Macapinlac, Homer A., Subbiah, Vivek
Publicado 2020

Radiomics Analysis for (177)Lu-DOTAGA-(l-y)fk(Sub-KuE) Targeted Radioligand Therapy Dosimetry in Metastatic Prostate Cancer—A Model Based on Clinical Example

por Kelk, Eve, Ruuge, Priit, Rohtla, Kristi, Poksi, Anne, Kairemo, Kalevi
Publicado 2021

[(18)F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Imaging in Oncology: Initial Staging and Evaluation of Cancer Therapy

por Pauwels, Ernest K.J., Coumou, Annette W., Kostkiewicz, Magdalena, Kairemo, Kalevi
Publicado 2013

A Retrospective Comparative Study of Sodium Fluoride Na(18)F-PET/CT and (68)Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis

por Kairemo, Kalevi, Kangasmäki, Aki, Kappadath, Srinivasan Cheenu, Joensuu, Timo, Macapinlac, Homer A.
Publicado 2022

Is interim (18)F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?

por Etchebehere, Elba, Brito, Ana Emília, Kairemo, Kalevi, Rohren, Eric, Araujo, John, Macapinlac, Homer
Publicado 2019

(177)Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer

por von Eyben, Finn E., Kiljunen, Timo, Joensuu, Timo, Kairemo, Kalevi, Uprimny, Christian, Virgolini, Irene
Publicado 2017

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

por Gouda, Mohamed A., Zarzour, Maria A., Vaporciyan, Ara A., Kairemo, Kalevi, Chuang, Hubert H., Subbiah, Vivek
Publicado 2023

Third-line treatment and (177)Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review

por von Eyben, Finn Edler, Roviello, Giandomenico, Kiljunen, Timo, Uprimny, Christian, Virgolini, Irene, Kairemo, Kalevi, Joensuu, Timo
Publicado 2017

Single Center Experience with a 4-Week (177)Lu-PSMA-617 Treatment Interval in Patients with Metastatic Castration-Resistant Prostate Cancer

por Kemppainen, Jukka, Kangasmäki, Aki, Malaspina, Simona, Pape, Bernd, Jalomäki, Jarno, Kairemo, Kalevi, Kononen, Juha, Joensuu, Timo
Publicado 2022